drug reps to give out information about unapproved uses of their prescription drugs
February 1999
The FDA will allow drug reps to give out information about UNAPPROVED uses of their prescription drugs.
Until now, drug reps could only give info about FDA-approved indications...even if their drug is commonly used "off-label."
That's why you've never seen a rep hand out info about verapamil for migraines...Neurontin for neuropathic pain...Wellbutrin for attention deficit disorder, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote